Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

05. November 2025 08:00 ET | Quelle: Curonix LLC

Curonix Strengthens Executive Leadership with Appointment of Leading Medical Device Executive Russell Fleeger as Chief Financial Officer to Drive Next Stage of Growth

Curonix Strengthens Executive Leadership with Appointment of Leading Medical Device Executive Russell Fleeger as Chief Financial Officer to Drive Next Stag
02. Oktober 2025 08:00 ET | Quelle: Curonix LLC

Curonix Publishes Results for the First and Only IDE PNS Multi-Center Randomized Clinical Trial Resulting in an FDA 510(k) Expanded Indication for Treating Chronic Craniofacial Pain

Curonix Publishes Results for IDE PNS Multi-Center Randomized Clinical Trial Resulting in an FDA Expanded Indication for Treating Chronic Craniofacial Pain
18. September 2025 08:00 ET | Quelle: Curonix LLC

Curonix Expands the Freedom® PNS System Patient Treatment Options with the Launch of its Innovative Wearable Solution for Chronic Pain of the Head, Neck, Shoulder, and Torso

Curonix Expands the Freedom® PNS System Patient Treatment Options with the Launch of its Innovative Wearable Solution
27. März 2025 08:00 ET | Quelle: Curonix LLC

Curonix Unveils NervPulse™ Therapy: Setting a New Standard in Nerve-Specific Peripheral Nerve Stimulation (PNS) Therapy

Curonix LLC proudly introduces NervPulseTherapy, an advanced, evidence-based programming platform designed to optimize peripheral nerve stimulation.